Sequence of actions for visualization of soft tissue hemorrhages/hematomas in elderly patients infected with SARS-CoV-2

Aim. To determine ultrasound, computed tomography and angiographic image characteristics for soft tissue hemorrhages/hematomas, the sequence of using imaging methods in patients infected with SARS-CoV-2, to study the morphology of changes in soft tissues, to determine the essence of the concept and to develop treatment tactics for this complication of COVID-19.

Material and methods. During 4 months of treatment of elderly patients (+60) infected with SARS-CoV-2, 40 patients were identified with soft tissue hemorrhages/hematomas, of which 26 (65%) patients with large hematomas (>10 cm in size and > 1000 ml in volume). The analysis of clinical and laboratory parameters, methods of instrumental diagnostics (ultrasound – 26 patients, CT – 10 patients, angiography – 9 patients, punctures – 6 patients) was carried out; autopsy material was studied in 11 cases.

Results. Image characteristics of hemorrhages/hematomas of soft tissue density were obtained using modern instrumental methods, and the sequence of application of visualization methods was determined. A tactic for managing a patient with stopped and ongoing bleeding has been developed. The morphological substrate of hemorrhagic complications in a new viral infection was studied. All patients were treated with conservative and minimally invasive procedures (embolization, puncture with pressure bandage). 15 patients (57.7%) recovered, 11 patients (42.3%) died from the progression of COVID-19 complications.

Conclusion. Comprehensive clinical and laboratory sequential instrumental diagnosis of soft tissue hemorrhages in COVID-19. Treatment should be conservative and significantly invasive. The use of the term “soft tissue hematoma” in SARS-CoV-2 infected patients is not a natural quality of the normal pathological process and should not be observed from our point of view.

1. Glybochko P.V., Fomin V.V., Avdeev S.N. et al. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2020; 29 (2): 21–29. http://doi.org/10.32756/0869-5490-2020-2-21-29 (In Russian)

2. Petrov V.I., Gerasimenko A.S., Kulakova I.S., Shatalova O.V., Amosov A.A., Gorbatenko V.S. Mechanisms of development of COVID-19 associated coagulopathy. Diagnostics. Treatment. Lekarstvennyj vestnik. 2021; 15 (2) (82): 21–27. (In Russian)

3. Liu X., Zhang X, Xiao Gao T. et al. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparininvolved treatment. MedRxiv. 2020.04.23. http://doi.org/10.1101/2020.04.23.20076851

4. Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020; 8 (5): 475–481. http://doi.org/10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir. Med. 2020; 8 (4): e26. PMID: 32105632; PMCID: PMC7102538.

5. Zhang B., Zhou X., Qiu Y. et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020; 15 (7): e0235458. http://doi.org/10.1371/journal.pone.0235458.

6. ibm.com [Internet] Downloading IBM SPSS Statistics 22; c2021 [cited 2021 May 21]. Available from: https://www.ibm.com/support/pages/downloading-ibm-spssstatistics-22.

7. Dohan A., Darnige L., Sapoval M., Pellerin O. Spontaneous soft tissue hematomas. Diagn. Interv. Imaging. 2015; 96 (7–8): 789–796. http://doi.org/10.1016/j.diii.2015.03.014

8. Kuhle W.G., Sheiman R.G. Detection of active colonic hemorrhage with use of helical CT: findings in a swine model. Radiology. 2003; 228 (3): 743–752. http://doi.org/10.1148/radiol.2283020756

9. Hamilton J.D., Kumaravel M., Censullo M.L. et al. Multidetector CT evaluation of active extravasation in blunt abdominal and pelvic trauma patients. Radiographics. 2008; 28 (6): 1603–1616. http://doi.org/10.1148/rg.286085522

10. Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N. Engl. J. Med. 2020; 383 (2): 120–128. http://doi.org/10.1056/NEJMoa2015432

11. Abrikosov A.I. Private pathological anatomy. Moscow: Medicine, 1947. 567 p. (In Russian)

12. Galstyan G.M. Coagulopathy in COVID-19. Pulmonologiya. 2020; 30 (5): 645–657. http://doi.org/10.18093/08690189-2020-30-5-645-657 (In Russian)

13. Fraissé M., Logre E., Pajot O. et al. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care. 2020; 24 (1): 275. http://doi.org/10.1186/s13054-020-03025-y

14. Kumar A., Arora A., Sharma P. et al. Clinical features of COVID-19 and factors associated with severe clinical course: A systematic review and meta-analysis. SSRN [Preprint]. 2020: 3566166. http://doi.org/10.2139/ssrn.3566166

15. Nadkarni G.N., Lala A., Bagiella E. et al. Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19. J. Am. Coll. Cardiol. 2020; 76 (16): 1815–1826. http://doi.org/10.1016/j.jacc.2020.08.041